Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 10 04 2019
accepted: 06 08 2019
pubmed: 16 8 2019
medline: 17 6 2020
entrez: 16 8 2019
Statut: epublish

Résumé

Vaccines aimed at inducing T cell responses to protect against human immunodeficiency virus (HIV) infection have been under development for more than 15 years. Replication-defective adenovirus (rAd) vaccine vectors are at the forefront of this work and have been tested extensively in the simian immunodeficiency virus (SIV) challenge macaque model. Vaccination with rAd vectors coding for SIV Gag or other nonenvelope proteins induces T cell responses that control virus load but disappointingly is unsuccessful so far in preventing infection, and attention has turned to inducing antibodies to the envelope. However, here we report that Mauritian cynomolgus macaques (MCM),

Identifiants

pubmed: 31413132
pii: JVI.00606-19
doi: 10.1128/JVI.00606-19
pmc: PMC6803269
pii:
doi:

Substances chimiques

Gene Products, gag 0
SAIDS Vaccines 0
Vaccines, DNA 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Almond et al.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Med Primatol. 2007 Jun;36(3):131-42
pubmed: 17517087
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20877-82
pubmed: 19933330
Nature. 2002 Jan 17;415(6869):331-5
pubmed: 11797011
PLoS One. 2012;7(10):e48038
pubmed: 23118924
Science. 2013 May 24;340(6135):1237874
pubmed: 23704576
Nature. 2009 Jan 1;457(7225):87-91
pubmed: 18997770
J Virol. 2005 Jul;79(14):8878-85
pubmed: 15994781
Nat Med. 2009 Mar;15(3):293-9
pubmed: 19219024
Am J Phys Anthropol. 1995 Feb;96(2):133-41
pubmed: 7755104
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
J Exp Med. 2017 Jul 3;214(7):1889-1899
pubmed: 28566275
J Exp Med. 1988 Oct 1;168(4):1211-24
pubmed: 2459295
Nature. 2014 Jan 23;505(7484):502-8
pubmed: 24352234
Nature. 2012 Nov 1;491(7422):129-33
pubmed: 23023123
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Virol. 2018 Oct 12;92(21):
pubmed: 30111562
Nature. 2012 Jan 04;482(7383):89-93
pubmed: 22217938
J Virol. 2013 Sep;87(17):9420-30
pubmed: 23804645
J Exp Med. 2009 May 11;206(5):1117-34
pubmed: 19414559
J Virol. 2017 Nov 14;91(23):
pubmed: 28904195
J Med Primatol. 2009 Feb;38(1):1-14
pubmed: 19018947
J Exp Med. 1993 Jul 1;178(1):27-47
pubmed: 8315383
J Virol. 2012 Jul;86(14):7596-604
pubmed: 22573864
J Virol. 2014 Oct;88(20):11648-57
pubmed: 25008917
Sci Transl Med. 2010 Mar 10;2(22):22ra18
pubmed: 20375000
J Immunol. 2004 Oct 1;173(7):4387-93
pubmed: 15383568
Science. 2016 Feb 12;351(6274):714-20
pubmed: 26797147
DNA Cell Biol. 1999 Aug;18(8):611-21
pubmed: 10463057
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
PLoS One. 2014 Feb 05;9(2):e88327
pubmed: 24505475
Vaccine. 2011 Mar 21;29(14):2582-9
pubmed: 21292005
J Virol. 2001 Jan;75(1):115-24
pubmed: 11119580
Ann Clin Lab Sci. 2001 Jan;31(1):75-84
pubmed: 11314865
J Exp Med. 1997 Mar 3;185(5):909-20
pubmed: 9120397
J Virol. 2005 Dec;79(24):15547-55
pubmed: 16306625
Vaccine. 2012 Jun 22;30(30):4465-75
pubmed: 22569124
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2308-12
pubmed: 7534418
Vaccine. 2012 Feb 21;30(9):1737-45
pubmed: 22178526
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
J Virol. 1994 Jul;68(7):4650-5
pubmed: 8207839
J Gen Virol. 2008 Sep;89(Pt 9):2240-51
pubmed: 18753233
Nat Med. 1997 Feb;3(2):205-11
pubmed: 9018240
J Exp Med. 2000 Oct 16;192(8):1105-13
pubmed: 11034600
J Virol. 2012 Oct;86(19):10533-9
pubmed: 22811518
J Virol. 1997 Nov;71(11):8497-503
pubmed: 9343207

Auteurs

Neil Almond (N)

Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom neil.almond@nibsc.org s.patterson@imperial.ac.uk.

Neil Berry (N)

Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Richard Stebbings (R)

Biotherapeutics Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Mark Preston (M)

Analytical Sciences Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Claire Ham (C)

Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Mark Page (M)

Division of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Debbie Ferguson (D)

Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Nicola Rose (N)

Division of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Bo Li (B)

Biotherapeutics Group, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Edward T Mee (ET)

Division of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Mark Hassall (M)

Division of Virology, National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, United Kingdom.

Christiane Stahl-Hennig (C)

German Primate Centre, Gottingen, Germany.

Takis Athanasopoulos (T)

School of Biological Sciences, Royal Holloway, University of London, Surrey, United Kingdom.

Timos Papagatsias (T)

Centre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.

Shanthi Herath (S)

Centre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.

Adel Benlahrech (A)

Centre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.

George Dickson (G)

School of Biological Sciences, Royal Holloway, University of London, Surrey, United Kingdom.

Andrea Meiser (A)

Centre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.

Steven Patterson (S)

Centre for Immunology and Vaccinology, Imperial College London, London, United Kingdom neil.almond@nibsc.org s.patterson@imperial.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH